WNT pathway and mammary carcinogenesis:: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type

被引:154
作者
Ugolini, F
Charafe-Jauffret, E
Bardou, VJ
Geneix, J
Adélaïde, J
Labat-Moleur, F
Penault-Llorca, F
Longy, M
Jacquemier, J
Birnbaum, D
Pébusque, MJ
机构
[1] INSERM, U119, IFR 57, Oncol Mol Lab, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, Dept Anat Pathol, F-13009 Marseille, France
[3] Inst J Paoli I Calmettes, Dept Biostat, F-13009 Marseille, France
[4] Inst J Paoli I Calmettes, Lab Biol Tumeurs, F-13009 Marseille, France
[5] CHRU, Pathol Cellulaire Lab, Grenoble, France
[6] Ctr Jean Perrin, Anat Pathol Lab, Clermont Ferrand, France
[7] Inst Bergonie, Bordeaux, France
关键词
breast cancer; tumor suppressor gene; in situ hybridization; chromosome; 8;
D O I
10.1038/sj.onc.1204706
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Secreted Frizzled-related protein 1 (SFRP1) encodes a member of a protein family that contains a cysteine-rich domain similar to the WNT-binding site of Frizzled receptors and regulates the WNT pathway. The WNT pathway is frequently altered in human cancers. We have defined the pattern of SFRP1 mRNA expression in the progression of breast cancer. We show that SFRP1 is expressed in the epithelial component of normal breast, in the in situ component of ductal carcinomas and is lost in more than 80% of invasive breast carcinomas except the medullary type. Loss of SFRP1 expression is correlated with the presence of hormonal receptors. Conversely, the maintenance of SFRP1 in carcinomas is correlated with the presence of lymphoplasmocytic stroma. No significant association was observed between SFRP1 status and the level of apoptosis in tumoral cells.
引用
收藏
页码:5810 / 5817
页数:8
相关论文
共 52 条
  • [1] Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling
    Bafico, A
    Gazit, A
    Pramila, T
    Finch, PW
    Yaniv, A
    Aaronson, SA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) : 16180 - 16187
  • [2] CHURCH GM, 1984, P NATL ACAD SCI USA, V81, P945
  • [3] Dale TC, 1996, CANCER RES, V56, P4320
  • [4] p53 mutation as a genetic trait of typical medullary breast carcinoma
    de Cremoux, P
    Salomon, AV
    Liva, S
    Dendale, R
    Bouchind'homme, B
    Martin, E
    Sastre-Garau, X
    Magdelenat, H
    Fourquet, A
    Soussi, T
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (07) : 641 - 643
  • [5] PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP
    ELSTON, CW
    ELLIS, IO
    [J]. HISTOPATHOLOGY, 1991, 19 (05) : 403 - 410
  • [6] Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action
    Finch, PW
    He, X
    Kelley, MJ
    Uren, A
    Schaudies, RP
    Popescu, NC
    Rudikoff, S
    Aaronson, SA
    Varmus, HE
    Rubin, JS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) : 6770 - 6775
  • [7] DETECTION OF DNA FRAGMENTATION IN APOPTOSIS - APPLICATION OF INSITU NICK TRANSLATION TO CELL-CULTURE SYSTEMS AND TISSUE-SECTIONS
    GOLD, R
    SCHMIED, M
    ROTHE, G
    ZISCHLER, H
    BREITSCHOPF, H
    WEKERLE, H
    LASSMANN, H
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1993, 41 (07) : 1023 - 1030
  • [8] Propagation and localization of Wnt signaling
    Gumbiner, BM
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (04) : 430 - 435
  • [9] Identification of c-MYC as a target of the APC pathway
    He, TC
    Sparks, AB
    Rago, C
    Hermeking, H
    Zawel, L
    da Costa, LT
    Morin, PJ
    Vogelstein, B
    Kinzler, KW
    [J]. SCIENCE, 1998, 281 (5382) : 1509 - 1512
  • [10] HUGUET EL, 1994, CANCER RES, V54, P2615